Biotechnology News
Cutting edge news about companies engaged in the research and development of new drugs, medical devices and procedures as well as research, books and information on FDA approvals, patents and awards. Biotechnology news highlights the use of biological processes, organisms or systems to manufacture products that improve the quality of life.
In 4 Weeks Meet Pfizer, AstraZeneca, DiME & Many More at the Biosensors for Medical Wearables Conference
SAE Media Group reports: The Biosensors for Medical Wearables Conference will welcome Pfizer, AstraZeneca, DiMe, MedRhythms and many more biotech companies. - September 26, 2022 - SAE Media Group
New Decentralized Clinical Trial (DCT) Patient Satisfaction and Participation Report
800 Current and Future Clinical Trial Participants Link Satisfaction and Willingness to Participate with Decentralized Strategies - September 21, 2022 - Life Science Strategy Group, LLC
Serpin Pharma Awarded Competitive NCI Grant for SP16
The National Cancer Institute awarded Serpin Pharma a $400,000 competitive R43 grant for the Pre-clinical validation of phase II peptide LRP-1 agonist to treat and prevent chemotherapy-induced peripheral neuropathy. The Principal Investigators are Serpin Pharma's CEO and Executive Chairperson, Dr. - September 20, 2022 - Serpin Pharma, LLC
Key Topics Not to Miss at the Wearable Injectors and Connected Devices Conference
SAE Media Group: key topics and presentations released for ahead of the Wearable Injectors and Connected Devices Conference. - September 01, 2022 - SAE Media Group
Creative Diagnostics Launches New Livestock Infectious Diseases Antigens
Creative Diagnostics announced the launch of more than 20 antigens for the development of veterinary infectious diseases diagnostics and vaccines. - August 26, 2022 - Creative Diagnostics
NanoCellect Biomedical Awarded $1.8M Federal Grant to Advance Imaging Flow Cytometry with Artificial Intelligence Technologies
NanoCellect Biomedical Inc., a leader in the development and manufacture of microfluidic cell sorting solutions for cell-based assays, today announced it has received a $1.8 million Phase II Small Business Innovation Research (SBIR) grant through the National Institutes of Health’s National... - August 24, 2022 - NanoCellect Biomedical
Key Presentations at the Medical Devices & IVD Conference Released
SAE Media Group reports: ahead of the conference in November, key presentations are released for the Medical Devices & IVD Conference. - August 18, 2022 - SAE Media Group
Respiratory Monitoring & AI Technologies – Hear More at the Biosensors for Medical Wearables Conference
SAE Media Group reports: the Biosensors for Medical Wearables Conference will cover AI technologies and respiratory monitoring. - August 17, 2022 - SAE Media Group
VMRD Begins Manufacturing Key Reagent for Detection of CWD by RT-QuIC
Veterinary Medical Research & Development (VMRD), Pullman, WA, has partnered with CWD Evolution, Fort Collins, CO, to provide state-of-the-art diagnostic reagents for detection of the abnormal prion associated with Chronic Wasting Disease (CWD). The control of CWD requires identification of... - August 09, 2022 - VMRD, Inc.
Hemanext Announces Publication of Hypoxic Blood Storage Study in Blood Advances
Research shows that hypoxic storage preserves faster oxygen unloading from red blood cells compared to standard conditions. - August 05, 2022 - Hemanext
Stable and Quality Supply of Phosphoramidites is a Reality at BOC Sciences
As an expert in chemistry, BOC Sciences understands how important the quality of phosphoramidite is to successful oligo synthesis and remarkably, it has taken concrete actions to manufacture certified products. - August 05, 2022 - BOC Sciences
BOC Sciences Shares Its Strategic Emphasis on NTPs During the Pandemic
"Whether your studies involve DNA sequencing, cDNA synthesis, RT-PCR, RCA, MDA, DNA labeling, in vitro transcription, siRNA synthesis, or RNA amplification, we stock hundreds of modified or natural NTPs to suit your various molecular biological applications," a BOC Sciences manager announces to the public. - August 05, 2022 - BOC Sciences
Creative Diagnostics Introduces New Cell-Based ELISA Services
Creative Diagnostics is offering comprehensive services for Cell-based ELISA that can measure the reduction of viral antigens in infected cells using anti-virus antibodies or compounds. - July 22, 2022 - Creative Diagnostics
Julia Harwood Promoted to Senior Vice President of Clinical Operations for New York Cancer & Blood Specialists
New York Cancer & Blood Specialists (NYCBS) announced today the appointment of Julia Harwood to Senior Vice President of Clinical Operations. https://nycancer.com/news/julia-harwood-promoted-to-senior-vice-president-of-clinical-operations-for-new-york-cancer-and-blood-specialists Harwood... - July 20, 2022 - New York Cancer & Blood Specialists
Mako Medical CEO Chad Price Announces Company Expansion in Virginia with the Alliance
Chad Price, CEO of Raleigh-based Mako Medical and Mako Medical Laboratories, announced the company is expanding its service throughout the state of Virginia by adding a new member to the laboratory Alliance. - July 18, 2022 - Mako Medical Laboratories
Chad Price, CEO of Raleigh-Based Mako Medical & Mako Medical Laboratories Launches a New Monkeypox Test
Chad Price, CEO of Mako Medical, recently announced his team has developed a monkeypox test. - July 18, 2022 - Mako Medical Laboratories
Michael Cerminaro to Succeed Marvin Woodall as CEO of Thrombolex Woodall to Remain Executive Chairman of the Board of Directors
Thrombolex today announced that its Board of Directors has named Michael Cerminaro Chief Executive Officer (CEO) of Thrombolex effective July 13, 2022, the date of the Company’s most recent Quarterly Board Meeting. Mr. Cerminaro will also retain his current title of President. Mr. Woodall,... - July 18, 2022 - Thrombolex, Inc.
Brochure Available for Biosensors for Medical Wearables Conference 2022
SAE Media Group reports: the full agenda and speaker line-up is now available for 2nd Annual Biosensors for Medical Wearables conference. - July 13, 2022 - SAE Media Group
PharmStars Announces Spring 2022 Accelerator Graduates: 11 Digital Health Startups Have Successfully Completed PharmStars’ Pharma-Focused Accelerator Program
PharmStars, the pharma-focused accelerator for digital health startups, announces the graduation of 11 startups from its Spring 2022 program. The graduates successfully completed the 10-week PharmaU program, which culminated with the Showcase Event held June 8-10 in Boston. The Showcase Event brought together the participating startups and PharmStars’ seven innovation-minded pharma members. - July 12, 2022 - PharmStars
Immundiagnostik and Preventis GmbH Go Beyond the Lab at the AACC’s Annual Scientific Meeting and Clinical Lab Expo
Immundiagnostik and Preventis GmbH will exhibit together at the upcoming AACC Clinical Lab Expo July 26-28 in Chicago, IL in support of improved patient care. - July 11, 2022 - Immundiagnostik, Inc.
ReproTech, LLC Welcomes New President & CEO, William Braun
ReproTech, LLC, the industry leader in human reproductive tissue cryogenic storage, is pleased to announce that William J. Braun has been selected as ReproTech’s new President and Chief Executive Officer. Braun assumed the role on April 4, 2022, and will be based in ReproTech’s Coconut Creek, FL location. - July 09, 2022 - ReproTech, LLC
Global Cancer Technology Successfully Concludes Glioblastoma Pre-Clinical Animal Studies with Impressive Results
Global Cancer Technology, a San Diego, CA biotechnology company, has successfully completed animal testing with GCT.GLIO.1, a PI3K selective inhibitor that can cross the blood brain barrier and modulate immune cell function. The company will advance the compound to Phase 1 clinical trials as a next step. - July 08, 2022 - Global Cancer Technology
Network with Johnson & Johnson, Springboard, BSI, AstraZeneca and Many More at the Wearable Injectors & Connected Devices Conference
SAE Media Group reports: The full agenda and speaker line-up are now available to download for the 3rd Annual Wearable Injectors and Connected Devices Conference, returning in October 2022. - July 08, 2022 - SAE Media Group
Terrain Health Partners with Novel Biotech Company Microgenesis to Offer Breakthrough Solutions for Infertility
Terrain Health, an international precision healthcare organization partners with novel biotechnology, science research company Microgenesis, to offer a natural and effective solution to restore fertility potential by identifying root cause of infertility issues, now shown to be linked to the health of the gut microbiome. - July 06, 2022 - Terrain Health Inc.
Hemanext Announces Appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East, and Africa
Hemanext Inc. (“Hemanext” or the “Company”), a leading innovator in blood processing and storage technology, today announced the appointment of Daan Kok as the Executive Vice President & General Manager of Hemanext for Europe, Middle East and Africa (EMEA). In his role,... - July 05, 2022 - Hemanext
Bench International Launches "Digitization of Healthcare Technology" Practice
Practice Supported by Visionaries in Digital Technology to Complement Bench’s 45+ Years in Life Sciences Executive Search - June 23, 2022 - Bench International
New Integrated Controls Streamline Essential Force Measurement
Mark-10 introduces the Series F family of force testers for quality control and process monitoring in manufacturing, research, and engineering applications. Suitable for diverse uses in the medical device, packaging, automotive, aerospace, and other industries, the Series F family integrates... - June 21, 2022 - Mark-10 Corporation
PharmStars Announces “Innovations in Real-World Evidence” Theme for Fall 2022 Accelerator
PharmStars, the pharma-focused accelerator for digital health startups, announces it is now accepting applications for its Fall 2022 cohort with the theme, “Innovations in Real-World Evidence.” - June 15, 2022 - PharmStars
Defined Bioscience Announces Formation of Scientific Advisory Board
Defined Bioscience, a life science tools company pioneering the development of next generation ingredients for cell culture, today announced the formation of its scientific advisory board (SAB). The SAB is comprised of a distinguished group of academic and industry experts who will advise the... - June 15, 2022 - Defined Bioscience Inc.
Creative Diagnostics Introduces CC50/IC50 Assay Services for Pharmaceutical Safety
Creative Diagnostics introduced CC50/IC50 testing services with a high level of detection sensitivity and accuracy. - June 11, 2022 - Creative Diagnostics
PharmStars Announces Showcase Pitch Event for Spring 2022 Cohort
PharmStars, the pharma-focused accelerator for digital health startups, announces the start of its Showcase Event on June 8, 2022. The digital health startups that participated in the 10-week accelerator program will make formal presentations to, and answer questions from, the pharma members of PharmStars. All of PharmStars’ seven members are participating in the Showcase Event. - June 08, 2022 - PharmStars
Creative Diagnostics Announces Antigens for Epstein-Barr Virus Antibody Tests
Creative Diagnostics recently launched recombinant antigens p18 and p23 (viral capsid antigens, VCA), p54 and p138 (early antigens, EA) and EBNA1 (nuclear antigen, EBNA). - May 26, 2022 - Creative Diagnostics
Molekule Consulting Announces the Launch of E.U. - Based Operations
Molekule Consulting announces the launch of an E.U. - based business / Molekule Hub continuing their focus on the development of global strategy and advisory services for the biopharmaceutical sector. - May 24, 2022 - Molekule Consulting
Biopharma Industry Standout Robert Proulx Joins Advisory Board of Global Cancer Technology
Global Cancer Technology is developing innovative treatments for deadly diseases like cancer, with a current focus on glioblastoma and breast cancer. To date, Mr. Robert Proulx has held numerous Board positions, is a recognized thought leader in biopharma, and currently holds dual roles as the founder and CEO of Imagion Biosystems. - May 21, 2022 - Global Cancer Technology
Vesalio Announces Oversubscribed Class A Financing
Vesalio, an emerging leader in improving outcomes in patients with vascular occlusion, is proud to announce it has oversubscribed its Class A financing round. Solas BioVentures led the investment with participation by new and existing investors, including the recent addition of Orlando Health... - May 18, 2022 - Vesalio
Terrain Health Expands, Offering Innovative Solutions to Patients in Direct Patient Care and in Natural and Effective Fertility Solutions
Terrain Health, an international, precision healthcare organization focusing on integrative and functional medicine utilizing next generation healthcare tools, is pleased to announce they are expanding their practice to best meet the needs of its patients. Terrain Health is now offering Direct... - May 09, 2022 - Terrain Health Inc.
DIY Cold Plates Can be Customized for Precise Attachment to Hot Electronic Devices
Advanced Thermal Solutions, Inc. (ATS) is now providing DIY (do it yourself) cold plates for engineers to custom fit onto devices whose electronics need to be thermally managed for proper performance. ATS’s family of DIY high-performance aluminum cold plates let engineers safely drill holes in patterns in a mounting pattern that matches the specific connection points of hot devices that need cooling, such as IGBTs, MOSFETs, or other power electronics. - May 09, 2022 - Advanced Thermal Solutions, Inc.
The ALS TDI Discovery Biology Suite Dedicated in Honor of Liz Bodine to Speed Drug Development in ALS
The ALS Therapy Development Institute (ALS TDI) and Augie’s Quest to Cure ALS are proud to honor the commitment of Liz Bodine to facilitate more effective ALS drug discovery at ALS TDI, the world’s most comprehensive drug discovery lab dedicated solely to ALS. - May 04, 2022 - ALS Therapy Development Institute
BioSource Celebrating 25 Years in Business
This May marks 25 years since the start of BioSource Cultures & Flavors Inc. Support, guidance, and friendship of customers have made this milestone possible. Since 1997, BioSource has grown organically, as a family business started by Dr. Narayan Suresh and his wife Archana Suresh as... - April 23, 2022 - BioSource Cultures and Flavors
Anderton SICAV Launches New High Income Investment Fund. Gamma Capital Markets Acts as Investment Manager.
Anderton, an investment company that includes Gamma Capital Markets as its Investment Manager, announces the launch of the Challenger Impact High Income Fund to raise a minimum of 15 million EUR in its first initial offering period from investors seeking opportunities in early stage companies,... - April 22, 2022 - Anderton SICAV Plc.
Best Medical Website to be Named by Web Marketing Association in 26th Annual WebAward Competition
The Web Marketing Association will name the best medical websites in the world as part of their 26th annual international WebAward Competition for Web site development. Medial Websites can be entered into consideration for the 2022 Best Medical Website and other medical-related WebAwards at www.webaward.org. - April 10, 2022 - Web Marketing Association
Instant Systems Expands Its Footprint in Virginia
Instant Systems continues to expand their footprint in Southeast Virginia with the launch of their Central Supply and Order Fulfilment Center (N3) in Virginia Beach, VA. Increased demand for Instant Systems’ products and services is driving the need for more warehouse, production and R&D... - April 07, 2022 - Instant Systems
New Immundiagnostik Test Simplifies Detecting, Measuring Unintentional Gluten Consumption
A quantitative test that detects gluten in stool samples is now available exclusively through Labcorp. - April 05, 2022 - Immundiagnostik, Inc.
EndoSoft® Announces ISO 13485:2016 Certification
EndoSoft, a Leading Health IT Company, announced today that they received ISO 13485:2016 Quality Management System Certification for the design, development, integration, and support of Electronic Health Record (EHR) and Artificial Intelligence (AI) software products (Registered by SRI Quality... - April 01, 2022 - EndoSoft
22 Year Breast Cancer Survivor Shines on the Catwalk to Bring Awareness to Genetic Testing
Crediting genetic testing and a persistent oncologist who kept recommending the testing at every checkup, Kathy is passionate about sharing the importance of genetic testing and how it saved her life. - April 01, 2022 - Say YES to Hope
Brandy Thibault Rocks the Runway to Illuminate Early Onset Colorectal Cancer
Brandy says, “Finding my purpose after cancer was extremely important and I have used it to help others my age; to make them aware that early onset colorectal cancer awareness is crucial.” - March 31, 2022 - Say YES to Hope
Kyle Clanton Brings Colorectal Cancer Awareness to the Catwalk Modeling Blue Shoes
Early onset colorectal cancer is a burgeoning problem in the United States and one that deserves greater attention. Kyle Clanton and his wife, Arriane Emdad, recently created a conversation during the Dallas Fashion Gala by modeling the catwalk in blue, the official color for colorectal cancer. - March 30, 2022 - Say YES to Hope
Denver City and County Building Lights Red for Bleeding Disorders Awareness
The Denver City and County Building located at 1437 Bannock Street was lit in magnificent red lights the week of March 2-7 in honor of Bleeding Disorders Awareness Month (BDAM). With about 3 million people nationwide impacted, it is critical to bring awareness to the important health condition and to advocate for access to diagnosis and ongoing health care. - March 12, 2022 - National Hemophilia Foundation - Colorado Chapter
AvantGen Awarded Contract from NIH to Expedite the Commercialization of Its AccuRate COVID-19 SelfCheck OTC Test
AvantGen, a San Diego-based biotechnology company with a superior yeast display technology for facile antibody discovery and optimization, has entered the National Institutes of Health (NIH) Rapid Acceleration of Diagnostics (RADx®) Tech program to expedite the commercialization of its... - March 09, 2022 - AvantGen
NuvOx Receives Notice from the Breakthrough DOD Award for Its Immuno-Oncology Program
On February 11th, 2022, NuvOx Pharma received notice from the Department of Defense (DOD) office of the Congressionally Directed Medical Research Programs (CDMRP) that the Company has been awarded a grant from the Breast Cancer Research Program Breakthrough Award. The grant would fund a... - March 05, 2022 - NuvOx Pharma